TickerFactsScreenerDevelopers

Vivos Therapeutics, Inc. (VVOS) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2019: $469.4K2020: $18.21M2021: $24.03M2022: $3.52M2023: $1.64M2024: $6.26M2025: $2.03M$2.03M
2019Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$2.03M-67.6%
2024$6.26M+281.0%
2023$1.64M-53.3%
2022$3.52M-85.4%
2021$24.03M+32.0%
2020$18.21M+3779.0%
2019$469.4K—